Global Lung Cancer Surgery Market Growth (Status and Outlook) 2024-2030

2024

Global Lung Cancer Surgery Market Growth (Status and Outlook) 2024-2030

Name: Global Lung Cancer Surgery Market Growth (Status and Outlook) 2024-2030
Brand: Bonafide Research
SKU: 95001172
Price: 3450 USD
Availability: InStock
Rating: 4 (12.35 reviews)

The global Lung Cancer Surgery market, valued at US$ 19,780 million in 2024, is growing due to advancements in medical technologies and treatments.

Bonafide Trust
09-09-2024
Pages : 109
Figures : 83
Tables : 100
Region : Global
Category : Lifescience & Healthcare
Healthcare

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global lung cancer surgery market is experiencing significant growth due to the increasing incidence of lung cancer and advancements in surgical technologies that are improving treatment outcomes for patients. Lung cancer is one of the most common and deadliest forms of cancer worldwide, and as the global population continues to age, the prevalence of lung cancer is expected to rise. Surgical treatment is one of the most effective options for lung cancer, particularly in the early stages when the tumor is localized and has not spread to other parts of the body. The growing awareness of the importance of early detection and intervention in improving survival rates is driving the demand for lung cancer surgery. Additionally, advancements in minimally invasive surgical techniques, such as video-assisted thoracic surgery (VATS) and robotic-assisted surgery, are making procedures less invasive, reducing recovery times, and improving overall patient outcomes. These innovations are contributing to the growth of the lung cancer surgery market, as patients seek less traumatic and more effective treatment options. Furthermore, the development of targeted therapies and immunotherapies is complementing surgical interventions, enabling better management of lung cancer and improving prognosis. The combination of these factors, along with increasing investments in healthcare infrastructure and rising healthcare awareness, is expected to drive the growth of the lung cancer surgery market in the coming years.

According to Publisher, the global Lung Cancer Surgery market size was valued at US$ 19780 million in 2024. With growing demand in downstream market, the Lung Cancer Surgery is forecast to a readjusted size of US$ 28980 million by 2030 with a CAGR of 5.6% during review period. The rising adoption of advanced technologies in lung cancer surgery, such as robotic surgery and computer-assisted navigation systems, is revolutionizing the surgical landscape and improving patient outcomes. Robotic-assisted surgery, in particular, has gained widespread acceptance in recent years due to its precision, minimal invasiveness, and shorter recovery times. This technology allows surgeons to perform complex procedures with greater accuracy and control, resulting in smaller incisions, reduced blood loss, and faster healing. The ability to visualize the surgical area in high definition and 3D also enhances the surgeon’s ability to detect and remove tumors more effectively. As the demand for minimally invasive surgeries continues to grow, the market for robotic-assisted lung cancer surgeries is expected to expand. Moreover, advancements in computer-assisted navigation systems are helping surgeons to map the lung anatomy in real time, improving accuracy during surgery and minimizing the risk of complications. These technological innovations are enhancing the overall efficiency of lung cancer surgeries, providing better outcomes for patients and making them more attractive options for both healthcare providers and patients.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

As a result, the global lung cancer surgery market is poised for significant growth as more healthcare facilities adopt these advanced technologies to improve treatment efficacy and patient satisfaction.
The lung cancer surgery market is segmented by type of surgery, including lobectomy, pneumonectomy, segmentectomy, and others. Lobectomy, which involves the removal of a lobe of the lung, is one of the most common surgeries for treating early-stage lung cancer. This procedure is highly effective in treating localized tumors and has a high success rate, making it the preferred surgical option for many patients. Lobectomy is particularly suitable for patients with non-small cell lung cancer (NSCLC), the most common form of lung cancer. Pneumonectomy, the removal of an entire lung, is typically performed in cases where the cancer has spread throughout one lobe and cannot be treated with a lobectomy. Although pneumonectomy is a more invasive procedure, it may be necessary to ensure complete removal of the cancerous tissue. Segmentectomy, a more conservative option that involves removing only a portion of the lung, is becoming increasingly popular for patients with small, localized tumors, particularly those who may not be suitable candidates for more extensive surgeries like lobectomy or pneumonectomy. This technique is associated with less lung function loss and a faster recovery time. Other surgical techniques used in lung cancer treatment include wedge resection and thoracotomy, which are less commonly performed but may be necessary depending on the location and extent of the tumor. As more personalized treatment approaches are being developed, the selection of the appropriate surgery type will be increasingly tailored to individual patients, contributing to the market’s growth and the advancement of lung cancer treatment.

The lung cancer surgery market is also segmented by application, including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and others. Non-small cell lung cancer is the most common type of lung cancer, accounting for around 85% of all cases. Due to its prevalence, the majority of lung cancer surgeries are performed for NSCLC patients. Surgical options for NSCLC patients are diverse, ranging from lobectomy and segmentectomy to pneumonectomy, depending on the size and location of the tumor. The early detection of NSCLC is crucial to improving treatment outcomes, and with advancements in imaging technologies such as CT scans, PET scans, and MRIs, physicians can more accurately assess the extent of the disease and plan surgical interventions accordingly. Small cell lung cancer, while less common, tends to be more aggressive and is often diagnosed at a later stage. Although surgery is not typically the first treatment option for SCLC due to its tendency to spread rapidly, it may be used in combination with chemotherapy and radiation therapy in limited-stage cases. The development of targeted therapies and immunotherapies has also opened up new possibilities for the treatment of both NSCLC and SCLC, allowing for more effective management of the disease and improving overall survival rates. The growing focus on early detection, personalized treatment approaches, and the availability of advanced surgical techniques are expected to drive the demand for lung cancer surgeries in both NSCLC and SCLC segments, further contributing to the growth of the global market.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lung Cancer Surgery Market Size 2019-2030
2.1.2 Lung Cancer Surgery Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Lung Cancer Surgery Segment by Type
2.2.1 Surgical Instruments
2.2.2 Monitoring And Visualization System
2.3 Lung Cancer Surgery Market Size by Type
2.3.1 Lung Cancer Surgery Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Lung Cancer Surgery Market Size Market Share by Type (2019-2024)
2.4 Lung Cancer Surgery Segment by Application
2.4.1 Lobectomy
2.4.2 Removal Of Sleeve
2.4.3 Regional Excision
2.4.4 Lung Removed All
2.4.5 Minimally Invasive Surgery
2.5 Lung Cancer Surgery Market Size by Application
2.5.1 Lung Cancer Surgery Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Lung Cancer Surgery Market Size Market Share by Application (2019-2024)
3 Lung Cancer Surgery Market Size by Player
3.1 Lung Cancer Surgery Market Size Market Share by Players
3.1.1 Global Lung Cancer Surgery Revenue by Players (2019-2024)
3.1.2 Global Lung Cancer Surgery Revenue Market Share by Players (2019-2024)
3.2 Global Lung Cancer Surgery Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Lung Cancer Surgery by Regions
4.1 Lung Cancer Surgery Market Size by Regions (2019-2024)
4.2 Americas Lung Cancer Surgery Market Size Growth (2019-2024)
4.3 APAC Lung Cancer Surgery Market Size Growth (2019-2024)
4.4 Europe Lung Cancer Surgery Market Size Growth (2019-2024)
4.5 Middle East & Africa Lung Cancer Surgery Market Size Growth (2019-2024)
5 Americas
5.1 Americas Lung Cancer Surgery Market Size by Country (2019-2024)
5.2 Americas Lung Cancer Surgery Market Size by Type (2019-2024)
5.3 Americas Lung Cancer Surgery Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lung Cancer Surgery Market Size by Region (2019-2024)
6.2 APAC Lung Cancer Surgery Market Size by Type (2019-2024)
6.3 APAC Lung Cancer Surgery Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Lung Cancer Surgery by Country (2019-2024)
7.2 Europe Lung Cancer Surgery Market Size by Type (2019-2024)
7.3 Europe Lung Cancer Surgery Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lung Cancer Surgery by Region (2019-2024)
8.2 Middle East & Africa Lung Cancer Surgery Market Size by Type (2019-2024)
8.3 Middle East & Africa Lung Cancer Surgery Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Lung Cancer Surgery Market Forecast
10.1 Global Lung Cancer Surgery Forecast by Regions (2025-2030)
10.1.1 Global Lung Cancer Surgery Forecast by Regions (2025-2030)
10.1.2 Americas Lung Cancer Surgery Forecast
10.1.3 APAC Lung Cancer Surgery Forecast
10.1.4 Europe Lung Cancer Surgery Forecast
10.1.5 Middle East & Africa Lung Cancer Surgery Forecast
10.2 Americas Lung Cancer Surgery Forecast by Country (2025-2030)
10.2.1 United States Lung Cancer Surgery Market Forecast
10.2.2 Canada Lung Cancer Surgery Market Forecast
10.2.3 Mexico Lung Cancer Surgery Market Forecast
10.2.4 Brazil Lung Cancer Surgery Market Forecast
10.3 APAC Lung Cancer Surgery Forecast by Region (2025-2030)
10.3.1 China Lung Cancer Surgery Market Forecast
10.3.2 Japan Lung Cancer Surgery Market Forecast
10.3.3 Korea Lung Cancer Surgery Market Forecast
10.3.4 Southeast Asia Lung Cancer Surgery Market Forecast
10.3.5 India Lung Cancer Surgery Market Forecast
10.3.6 Australia Lung Cancer Surgery Market Forecast
10.4 Europe Lung Cancer Surgery Forecast by Country (2025-2030)
10.4.1 Germany Lung Cancer Surgery Market Forecast
10.4.2 France Lung Cancer Surgery Market Forecast
10.4.3 UK Lung Cancer Surgery Market Forecast
10.4.4 Italy Lung Cancer Surgery Market Forecast
10.4.5 Russia Lung Cancer Surgery Market Forecast
10.5 Middle East & Africa Lung Cancer Surgery Forecast by Region (2025-2030)
10.5.1 Egypt Lung Cancer Surgery Market Forecast
10.5.2 South Africa Lung Cancer Surgery Market Forecast
10.5.3 Israel Lung Cancer Surgery Market Forecast
10.5.4 Turkey Lung Cancer Surgery Market Forecast
10.5.5 GCC Countries Lung Cancer Surgery Market Forecast
10.6 Global Lung Cancer Surgery Forecast by Type (2025-2030)
10.7 Global Lung Cancer Surgery Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Accuray
11.1.1 Accuray Company Information
11.1.2 Accuray Lung Cancer Surgery Product Offered
11.1.3 Accuray Lung Cancer Surgery Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Accuray Main Business Overview
11.1.5 Accuray Latest Developments
11.2 Angiodynamics
11.2.1 Angiodynamics Company Information
11.2.2 Angiodynamics Lung Cancer Surgery Product Offered
11.2.3 Angiodynamics Lung Cancer Surgery Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Angiodynamics Main Business Overview
11.2.5 Angiodynamics Latest Developments
11.3 Ethicon
11.3.1 Ethicon Company Information
11.3.2 Ethicon Lung Cancer Surgery Product Offered
11.3.3 Ethicon Lung Cancer Surgery Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Ethicon Main Business Overview
11.3.5 Ethicon Latest Developments
11.4 Intuitive Surgical
11.4.1 Intuitive Surgical Company Information
11.4.2 Intuitive Surgical Lung Cancer Surgery Product Offered
11.4.3 Intuitive Surgical Lung Cancer Surgery Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Intuitive Surgical Main Business Overview
11.4.5 Intuitive Surgical Latest Developments
11.5 Olympus
11.5.1 Olympus Company Information
11.5.2 Olympus Lung Cancer Surgery Product Offered
11.5.3 Olympus Lung Cancer Surgery Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Olympus Main Business Overview
11.5.5 Olympus Latest Developments
11.6 Teleflex
11.6.1 Teleflex Company Information
11.6.2 Teleflex Lung Cancer Surgery Product Offered
11.6.3 Teleflex Lung Cancer Surgery Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Teleflex Main Business Overview
11.6.5 Teleflex Latest Developments
11.7 Ackermann Instrumente
11.7.1 Ackermann Instrumente Company Information
11.7.2 Ackermann Instrumente Lung Cancer Surgery Product Offered
11.7.3 Ackermann Instrumente Lung Cancer Surgery Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Ackermann Instrumente Main Business Overview
11.7.5 Ackermann Instrumente Latest Developments
11.8 Karl Storz
11.8.1 Karl Storz Company Information
11.8.2 Karl Storz Lung Cancer Surgery Product Offered
11.8.3 Karl Storz Lung Cancer Surgery Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Karl Storz Main Business Overview
11.8.5 Karl Storz Latest Developments
11.9 Scanlan International
11.9.1 Scanlan International Company Information
11.9.2 Scanlan International Lung Cancer Surgery Product Offered
11.9.3 Scanlan International Lung Cancer Surgery Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Scanlan International Main Business Overview
11.9.5 Scanlan International Latest Developments
11.10 Trokamed
11.10.1 Trokamed Company Information
11.10.2 Trokamed Lung Cancer Surgery Product Offered
11.10.3 Trokamed Lung Cancer Surgery Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Trokamed Main Business Overview
11.10.5 Trokamed Latest Developments
12 Research Findings and Conclusion

Table 1. Lung Cancer Surgery Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Surgical Instruments
Table 3. Major Players of Monitoring And Visualization System
Table 4. Lung Cancer Surgery Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Lung Cancer Surgery Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Lung Cancer Surgery Market Size Market Share by Type (2019-2024)
Table 7. Lung Cancer Surgery Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Lung Cancer Surgery Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Lung Cancer Surgery Market Size Market Share by Application (2019-2024)
Table 10. Global Lung Cancer Surgery Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Lung Cancer Surgery Revenue Market Share by Player (2019-2024)
Table 12. Lung Cancer Surgery Key Players Head office and Products Offered
Table 13. Lung Cancer Surgery Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Lung Cancer Surgery Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Lung Cancer Surgery Market Size Market Share by Regions (2019-2024)
Table 18. Global Lung Cancer Surgery Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Lung Cancer Surgery Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Lung Cancer Surgery Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Lung Cancer Surgery Market Size Market Share by Country (2019-2024)
Table 22. Americas Lung Cancer Surgery Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Lung Cancer Surgery Market Size Market Share by Type (2019-2024)
Table 24. Americas Lung Cancer Surgery Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Lung Cancer Surgery Market Size Market Share by Application (2019-2024)
Table 26. APAC Lung Cancer Surgery Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Lung Cancer Surgery Market Size Market Share by Region (2019-2024)
Table 28. APAC Lung Cancer Surgery Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Lung Cancer Surgery Market Size Market Share by Type (2019-2024)
Table 30. APAC Lung Cancer Surgery Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Lung Cancer Surgery Market Size Market Share by Application (2019-2024)
Table 32. Europe Lung Cancer Surgery Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Lung Cancer Surgery Market Size Market Share by Country (2019-2024)
Table 34. Europe Lung Cancer Surgery Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Lung Cancer Surgery Market Size Market Share by Type (2019-2024)
Table 36. Europe Lung Cancer Surgery Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Lung Cancer Surgery Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Lung Cancer Surgery Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Lung Cancer Surgery Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Lung Cancer Surgery Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Lung Cancer Surgery Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Lung Cancer Surgery Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Lung Cancer Surgery Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Lung Cancer Surgery
Table 45. Key Market Challenges & Risks of Lung Cancer Surgery
Table 46. Key Industry Trends of Lung Cancer Surgery
Table 47. Global Lung Cancer Surgery Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Lung Cancer Surgery Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Lung Cancer Surgery Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Lung Cancer Surgery Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Accuray Details, Company Type, Lung Cancer Surgery Area Served and Its Competitors
Table 52. Accuray Lung Cancer Surgery Product Offered
Table 53. Accuray Lung Cancer Surgery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Accuray Main Business
Table 55. Accuray Latest Developments
Table 56. Angiodynamics Details, Company Type, Lung Cancer Surgery Area Served and Its Competitors
Table 57. Angiodynamics Lung Cancer Surgery Product Offered
Table 58. Angiodynamics Main Business
Table 59. Angiodynamics Lung Cancer Surgery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Angiodynamics Latest Developments
Table 61. Ethicon Details, Company Type, Lung Cancer Surgery Area Served and Its Competitors
Table 62. Ethicon Lung Cancer Surgery Product Offered
Table 63. Ethicon Main Business
Table 64. Ethicon Lung Cancer Surgery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Ethicon Latest Developments
Table 66. Intuitive Surgical Details, Company Type, Lung Cancer Surgery Area Served and Its Competitors
Table 67. Intuitive Surgical Lung Cancer Surgery Product Offered
Table 68. Intuitive Surgical Main Business
Table 69. Intuitive Surgical Lung Cancer Surgery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Intuitive Surgical Latest Developments
Table 71. Olympus Details, Company Type, Lung Cancer Surgery Area Served and Its Competitors
Table 72. Olympus Lung Cancer Surgery Product Offered
Table 73. Olympus Main Business
Table 74. Olympus Lung Cancer Surgery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Olympus Latest Developments
Table 76. Teleflex Details, Company Type, Lung Cancer Surgery Area Served and Its Competitors
Table 77. Teleflex Lung Cancer Surgery Product Offered
Table 78. Teleflex Main Business
Table 79. Teleflex Lung Cancer Surgery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Teleflex Latest Developments
Table 81. Ackermann Instrumente Details, Company Type, Lung Cancer Surgery Area Served and Its Competitors
Table 82. Ackermann Instrumente Lung Cancer Surgery Product Offered
Table 83. Ackermann Instrumente Main Business
Table 84. Ackermann Instrumente Lung Cancer Surgery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Ackermann Instrumente Latest Developments
Table 86. Karl Storz Details, Company Type, Lung Cancer Surgery Area Served and Its Competitors
Table 87. Karl Storz Lung Cancer Surgery Product Offered
Table 88. Karl Storz Main Business
Table 89. Karl Storz Lung Cancer Surgery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Karl Storz Latest Developments
Table 91. Scanlan International Details, Company Type, Lung Cancer Surgery Area Served and Its Competitors
Table 92. Scanlan International Lung Cancer Surgery Product Offered
Table 93. Scanlan International Main Business
Table 94. Scanlan International Lung Cancer Surgery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Scanlan International Latest Developments
Table 96. Trokamed Details, Company Type, Lung Cancer Surgery Area Served and Its Competitors
Table 97. Trokamed Lung Cancer Surgery Product Offered
Table 98. Trokamed Main Business
Table 99. Trokamed Lung Cancer Surgery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Trokamed Latest Developments

Figure 1. Lung Cancer Surgery Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Lung Cancer Surgery Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Lung Cancer Surgery Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Lung Cancer Surgery Sales Market Share by Country/Region (2023)
Figure 8. Lung Cancer Surgery Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Lung Cancer Surgery Market Size Market Share by Type in 2023
Figure 10. Lung Cancer Surgery in Lobectomy
Figure 11. Global Lung Cancer Surgery Market: Lobectomy (2019-2024) & ($ Millions)
Figure 12. Lung Cancer Surgery in Removal Of Sleeve
Figure 13. Global Lung Cancer Surgery Market: Removal Of Sleeve (2019-2024) & ($ Millions)
Figure 14. Lung Cancer Surgery in Regional Excision
Figure 15. Global Lung Cancer Surgery Market: Regional Excision (2019-2024) & ($ Millions)
Figure 16. Lung Cancer Surgery in Lung Removed All
Figure 17. Global Lung Cancer Surgery Market: Lung Removed All (2019-2024) & ($ Millions)
Figure 18. Lung Cancer Surgery in Minimally Invasive Surgery
Figure 19. Global Lung Cancer Surgery Market: Minimally Invasive Surgery (2019-2024) & ($ Millions)
Figure 20. Global Lung Cancer Surgery Market Size Market Share by Application in 2023
Figure 21. Global Lung Cancer Surgery Revenue Market Share by Player in 2023
Figure 22. Global Lung Cancer Surgery Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Lung Cancer Surgery Market Size 2019-2024 ($ Millions)
Figure 24. APAC Lung Cancer Surgery Market Size 2019-2024 ($ Millions)
Figure 25. Europe Lung Cancer Surgery Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Lung Cancer Surgery Market Size 2019-2024 ($ Millions)
Figure 27. Americas Lung Cancer Surgery Value Market Share by Country in 2023
Figure 28. United States Lung Cancer Surgery Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Lung Cancer Surgery Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Lung Cancer Surgery Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Lung Cancer Surgery Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Lung Cancer Surgery Market Size Market Share by Region in 2023
Figure 33. APAC Lung Cancer Surgery Market Size Market Share by Type in 2023
Figure 34. APAC Lung Cancer Surgery Market Size Market Share by Application in 2023
Figure 35. China Lung Cancer Surgery Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Lung Cancer Surgery Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Lung Cancer Surgery Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Lung Cancer Surgery Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Lung Cancer Surgery Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Lung Cancer Surgery Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Lung Cancer Surgery Market Size Market Share by Country in 2023
Figure 42. Europe Lung Cancer Surgery Market Size Market Share by Type (2019-2024)
Figure 43. Europe Lung Cancer Surgery Market Size Market Share by Application (2019-2024)
Figure 44. Germany Lung Cancer Surgery Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Lung Cancer Surgery Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Lung Cancer Surgery Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Lung Cancer Surgery Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Lung Cancer Surgery Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Lung Cancer Surgery Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Lung Cancer Surgery Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Lung Cancer Surgery Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Lung Cancer Surgery Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Lung Cancer Surgery Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Lung Cancer Surgery Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Lung Cancer Surgery Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Lung Cancer Surgery Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 58. APAC Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 59. Europe Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 61. United States Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 62. Canada Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 65. China Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 66. Japan Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 67. Korea Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 69. India Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 70. Australia Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 71. Germany Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 72. France Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 73. UK Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 74. Italy Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 75. Russia Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 76. Spain Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 79. Israel Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Lung Cancer Surgery Market Size 2025-2030 ($ Millions)
Figure 82. Global Lung Cancer Surgery Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Lung Cancer Surgery Market Size Market Share Forecast by Application (2025-2030)

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted